Predictors of myocardial dysfunction in human immunodeficiency virus-infected patients.
暂无分享,去创建一个
F. Rocha‐Gonçalves | J. Silva-Cardoso | A. Ferreira | L. Martins | M. Cerqueira-Gomes | B. Moura | A. Mota-Miranda | H. Lecour | D. Bravo-Faria | F. Rocha-Gonçalves | José Silva-Cardoso | Brenda Moura | António Ferreira | Luís Martins | Duarte Bravo-Faria | Henrique Lecour | Mário Cerqueira-Gomes
[1] R. Lederman,et al. Cardiovascular involvement in AIDS. , 1997, Current problems in cardiology.
[2] A. Herskowitz. Cardiomyopathy and other symptomatic heart diseases associated with HIV infection. , 1996, Current opinion in cardiology.
[3] D. Vlahov,et al. Dilated heart muscle disease associated with HIV infection. , 1995, European heart journal.
[4] A. Katz. Cell death in the failing heart: Role of an unnatural growth response to overload–Cell death in the failing heart , 1995, Clinical cardiology.
[5] R. Brettle,et al. Heart muscle disease related to HIV infection: prognostic implications , 1994, BMJ.
[6] C. Conde,et al. Cardiac morbidity in the human immunodeficiency virus infection. , 1994, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.
[7] D. Vlahov,et al. Mycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus , 1994 .
[8] S. De Castro,et al. Frequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infection. , 1994, Journal of the American College of Cardiology.
[9] D. Vlahov,et al. Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection. , 1993, The American journal of cardiology.
[10] D. Vlahov,et al. Frequency of left ventricular dysfunction and other echocardiographic abnormalities in human immunodeficiency virus seronegative intravenous drug users. , 1993, The American journal of cardiology.
[11] R. Brettle,et al. Myocardial dysfunction in patients infected with HIV: prevalence and risk factors , 1992, British heart journal.
[12] S. De Castro,et al. Heart involvement in AIDS: a prospective study during various stages of the disease. , 1992, European heart journal.
[13] H. Kessler,et al. AIDS: Part II. , 1992, Disease-a-month : DM.
[14] K. Baughman,et al. Cardiomyopathy Associated with Antiretroviral Therapy in Patients with HIV Infection: A Report of Six Cases , 1992, Annals of Internal Medicine.
[15] A. Herskowitz,et al. Incidental myocarditis with intravenous drug abuse: the pathology, immunopathology, and potential implications for human immunodeficiency virus-associated myocarditis. , 1992, Human pathology.
[16] D. Ouellette,et al. Serum angiotensin-converting enzyme level is elevated in patients with human immunodeficiency virus infection. , 1992, Archives of internal medicine.
[17] F. Marumo,et al. Plasma endothelin-1 levels in idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.
[18] H. Fillit,et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.
[19] W. Grody,et al. Infection of the heart by the human immunodeficiency virus. , 1990, The American journal of cardiology.
[20] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[21] D. Chernoff,et al. Cardiac manifestations of human immunodeficiency virus infection: a two-dimensional echocardiographic study. , 1989, Journal of the American College of Cardiology.
[22] D. Abrams,et al. Clinical manifestations of HIV infection , 1989 .
[23] W. Rozenbaum,et al. Comparison among acquired immune deficiency syndrome patients with and without clinical evidence of cardiac disease. , 1988, The American journal of cardiology.
[24] M. Moroni,et al. Echocardiography detects myocardial damage in AIDS: prospective study in 102 patients. , 1988, European heart journal.
[25] James F. Martin. Echocardiography. 4th ed , 1986 .
[26] W. Greeley. Cardiac Catheterization and Angiography (3rd ed.) , 1986 .
[27] N. Hollenberg,et al. Relation of the Renin‐Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure , 1981, Circulation.
[28] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.
[29] B. Moura,et al. Zidovudine therapy and left ventricular function and mass in human immunodeficiency virus-infected patients. , 1997, Cardiology.
[30] J. Cohn. The Sympathetic Nervous System in Heart Failure , 1989, Journal of cardiovascular pharmacology.
[31] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[32] Moshe Y. Vardi,et al. Acute delirious state after epsilon-aminocaproic acid. , 1978, Lancet.
[33] William Grossman,et al. Cardiac catheterization and angiography , 1974 .
[34] V. Fuster. Hurst's the Heart , 1966 .